BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3441405)

  • 1. [Follow-up of 145 cases of breast carcinoma with receptor status simultaneously determined by histochemical and biochemical methods].
    Gubetta L; De Giuli P
    Pathologica; 1987; 79(1059-1060):179-85. PubMed ID: 3441405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Receptor correlation between histochemical and biochemical methods in advanced breast carcinoma].
    Simone G; Paradiso A; Labriola A; Petroni S; Tommasi S; Schittulli F
    Pathologica; 1987; 79(1059-1060):113-8. PubMed ID: 3441401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Follow-up of patients with receptor state determined by radiometric and histochemical methods].
    De Giuli P; Gubetta L
    Pathologica; 1985; 77(1049):311-4. PubMed ID: 3008070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm].
    Campobasso O; Concina S; Cozzani C; Ribotta M; Di Carlo F; Conti G; Racca S
    Pathologica; 1987; 79(1059-1060):53-9. PubMed ID: 3441412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlation between receptor status histochemically determined and clinical course in tumors of the breast: execution and extension of the study].
    Gottardi O; Franchi L; Ghislandi E
    Pathologica; 1987; 79(1059-1060):141-7. PubMed ID: 3441404
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of estrogen receptors of breast carcinoma with the PAP method. Retrospective study from 1979 to 1985].
    Giudici M; Cartia GL; Ciambellotti E; Langè A
    Pathologica; 1987; 79(1059-1060):61-3. PubMed ID: 3327047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Estrogen and progesterone receptors in cancer of the female breast: correlation with the age of the patients, fertility status, tumor stage and grading].
    Bracali G; De Magistris A; Olivieri D; Loli MG; Bracali M; Caracino AM; Marinucci R
    Pathologica; 1986; 78(1054):179-94. PubMed ID: 3822562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various methods for the determination of receptors: how effective and how used in clinical medicine?].
    Luproini G; Tabiadon D
    Pathologica; 1987; 79(1059-1060):159-64. PubMed ID: 3327041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between histological parameters and receptor status of tumors of the breast: analysis of a homogeneous population from Mantua].
    Dina R; Bellomi A
    Pathologica; 1987; 79(1059-1060):91-6. PubMed ID: 3441415
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors associated with prognosis in human breast cancer. V. The simultaneous use of estrogen and progesterone receptor measurements for prediction of short-term relapse.
    Pascual MR; Macías A; Moreno L; Lage A
    Neoplasma; 1985; 32(2):247-56. PubMed ID: 4000312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of histologically determined receptor state and the clinical course in tumors of the breast].
    Ghislandi E; Gottardi O
    Pathologica; 1985; 77(1049):323-35. PubMed ID: 3831883
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic value of hormonal receptors].
    Paradiso A; De Lena M
    Pathologica; 1987; 79(1059-1060):165-76. PubMed ID: 3327042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
    Scharl A; Vierbuchen M; Würz H
    Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the mechanism of the estrogen action in human breast cancer].
    Kimura M; Nishimura R; Akagi M
    Gan No Rinsho; 1985 Mar; 31(3):263-7. PubMed ID: 3999388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone receptor assessment for endocrine therapy in advanced breast cancer. Report of 28 cases.
    Chen PZ; Mei ZJ; Yao XY; Meng XQ
    Chin Med J (Engl); 1983 Oct; 96(10):751-3. PubMed ID: 6426873
    [No Abstract]   [Full Text] [Related]  

  • 18. [Standardization of receptor diagnosis in breast cancer].
    Hickler W; Scheiermann N; Riffelmann HD; Kreuzfelder E
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1931-3. PubMed ID: 3780470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Receptor status of cytologic material in primary and secondary breast tumors].
    Stagni F; Lampertico P
    Pathologica; 1987; 79(1059-1060):125-30. PubMed ID: 3441402
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
    Lampertico P; Stagni F
    Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.